Intravenous amoxicillin-sulbactam against Escherichia coli: optimizing the dose, component ratio and infusion time

C Bantar1, L Fernandez Canigia, M A Berger

  • 1Laboratorio Domingo I Nanni (Paraná), Hospital Alemán, Buenos Aires, Argentina. cbantar@arnet.com.ar

Insights

The optimal amoxicillin-sulbactam (AMX-SUL) formulation for treating E. coli infections is 1g/1g, especially when infused over 3 hours. Extended infusion enhances AMX-SUL

Area of Science:

  • Pharmacology
  • Microbiology
  • Infectious Diseases

Background:

  • Amoxicillin-sulbactam (AMX-SUL) is an antibiotic combination used for intra-abdominal infections.
  • Optimizing AMX-SUL dosage and ratio is crucial for effective treatment against resistant bacteria like Escherichia coli.

Purpose of the Study:

  • To determine the optimal dose and ratio of amoxicillin-sulbactam (AMX-SUL) components.
  • To evaluate the ex-vivo pharmacodynamic activity of AMX-SUL against Escherichia coli using a human pharmacodynamic model.

Main Methods:

  • Four volunteers received single doses of AMX-SUL with varying ratios (1/0.5, 1/1, 2/0.5 g/g) and infusion times (30 min or 3h).
  • Time-kill studies were conducted using post-dosing sera against two strains of E. coli with different susceptibility profiles.
  • Minimum Inhibitory Concentrations (MICs) for amoxicillin (AMX) and AMX-SUL were determined for each E. coli strain.

Main Results:

  • The 1g/1g ratio infused over 3 hours demonstrated superior and prolonged antimicrobial activity against both E. coli strains compared to other ratios and infusion times.
  • Extended 3-hour infusion of AMX-SUL (1g/1g and 1g/0.5g) significantly improved its pharmacodynamic profile.
  • AMX-SUL 1g/1g infused over 3 hours showed sustained bactericidal activity up to 4 hours post-dose against E. coli ATCC 25922.

Conclusions:

  • The 1g/1g formulation of amoxicillin-sulbactam is suggested as the optimal ratio for treating E. coli infections.
  • Extended infusion over 3 hours enhances the pharmacodynamic activity of AMX-SUL, making it more effective.
  • Clinical trials are recommended to validate the efficacy of extended-infusion AMX-SUL for community-acquired intra-abdominal infections.

Related Concept Videos

Estimation of k and VD of Aminoglycosides01:20

Estimation of k and VD of Aminoglycosides

Aminoglycosides are a class of antibiotics used to treat various bacterial infections. Clinicians must determine the elimination rate constant (k) and volume of distribution (VD) to optimize therapeutic efficacy and minimize toxicity. The k value represents the rate at which the drug is removed from the body, and the VD reflects the degree to which the drug distributes into body tissues. Accurately estimating these parameters allows healthcare professionals to tailor drug dosing to individual...
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
Dosage Interval and Administration Route: Determination Methods01:19

Dosage Interval and Administration Route: Determination Methods

A medication’s effectiveness largely depends on its appropriate dosage and the route of administration. Dosage ensures that a sufficient drug concentration is maintained in the bloodstream to elicit the desired therapeutic effect without causing toxicity. The route of administration affects the drug's bioavailability, rate of absorption, and onset of action, which are crucial for achieving optimal therapeutic outcomes. Drug dosage calculations are critical to tailoring therapy to individual...
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
Pharmacodynamic Models: Overview01:27

Pharmacodynamic Models: Overview

Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...
One-Compartment Model: IV Infusion01:09

One-Compartment Model: IV Infusion

Intravenous (IV) infusion is often utilized when continuous and controlled drug delivery is necessary, such as during surgery or in the treatment of chronic diseases. This method offers numerous advantages, including immediate drug action, precise control over dosage, and bypassing the first-pass metabolism.
The one-compartment model for IV infusion uses mathematical equations to describe the rate of change in drug quantity in the body. At steady-state or infusion equilibrium, the drug input...